Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | HGF | 96.0 | 45 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | HGF | 63.0 | 61 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | HGF | 69.0 | 55 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | HGF | 62.5 | 52 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | HGF | 49.0 | 53 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | HGF | 58.0 | 64 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | HGF | 78.0 | 65 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 4 | HGF | 71.0 | 53 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | HGF | 69.0 | 57 | |
N2645 | IL-1 alpha | 100 | ng/mL | 4 | HGF | 78.0 | 45 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | HGF | 65.0 | 37 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 4 | HGF | 59.0 | 45 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | HGF | 40.5 | 52 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | HGF | 34.0 | 58 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | HGF | 39.0 | 57 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | HGF | 35.0 | 48 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | HGF | 28.0 | 44 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | HGF | 34.0 | 58 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | HGF | 42.0 | 41 | |
RA2159 | TNF-a | 100 | ng/mL | 4 | HGF | 56.5 | 46 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | HGF | 57.0 | 41 | |
N2645 | TNF-a | 100 | ng/mL | 4 | HGF | 47.0 | 49 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | HGF | 31.0 | 45 | |
RA2708 | TNF-a | 100 | ng/mL | 4 | HGF | 36.0 | 45 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 4 | HGF | 73.0 | 37 |